Basics Natera, Inc. Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity. IPO Date: July 2, 2015 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $33.75B Activated in VL: True Average Daily Range Avg Daily Range: $1.27 | 2.45% Avg Daily Range (30 D): $4.07 | 1.97% Avg Daily Range (90 D): $3.33 | 1.86% Institutional Daily Volume Avg Daily Volume: .75M Avg Daily Volume (30 D): 1.36M Avg Daily Volume (90 D): 1.14M Trade Size Avg Trade Size (Sh.): 64 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 43 Institutional Trades Total Inst.Trades: 7,072 Avg Inst. Trade: $5.14M Avg Inst. Trade (30 D): $11.42M Avg Inst. Trade (90 D): $12.55M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $10.34M Avg Closing Trade (30 D): $26.13M Avg Closing Trade (90 D): $28.36M Avg Closing Volume: 126.39K     News Dec 5, 2025 @ 6:33 PM Why Is Adaptive Biotechnologies Stock Trading Lowe... Source: Vandana Singh Dec 5, 2025 @ 3:05 PM Natera Buys Foresight To Boost Super-Early Cancer ... Source: Vandana Singh Nov 30, 2025 @ 8:14 AM 30% of Billionaire Stanley Druckenmiller's Portfol... Source: Bram Berkowitz Aug 22, 2025 @ 1:00 PM Global Liquid Biopsy Market Set to Reach USD 7.05 ... Source: Marketsandmarkets Aug 6, 2025 @ 9:14 AM Personalis (PSNL) Q2 Revenue Falls 24% Source: Na Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.29 $-.64 $-.74 Diluted EPS $-2.29 $-.64 $-.74 Revenue $ 2.12B $ 592.18M $ 546.6M Gross Profit $ $ $ Net Income / Loss $ -309.19M $ -87.54M $ -100.94M Operating Income / Loss $ -351.87M $ -97.58M $ -110.37M Cost of Revenue $ $ $ Net Cash Flow $ 148.59M $ 41.42M $ 26.25M PE Ratio